<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Jackson N</submitter><funding>BioAmp</funding><funding>NIAID NIH HHS</funding><funding>HHS | NIH | National Institute of Allergy and Infectious Diseases</funding><pagination>e0047122</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9769571</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>7(6)</volume><pubmed_abstract>Antimicrobial resistance in urinary tract infections (UTIs) is a major public health concern. This study aims to characterize the phenotypic and genetic basis of multidrug resistance (MDR) among expanded-spectrum cephalosporin-resistant (ESCR) uropathogenic Escherichia coli (UPEC) causing UTIs in California patient populations. Between February and October 2019, 577 ESCR UPEC isolates were collected from patients at 6 clinical laboratory sites across California. Lineage and antibiotic resistance genes were determined by analysis of whole-genome sequence data. The lineages ST131, ST1193, ST648, and ST69 were predominant, representing 46%, 5.5%, 4.5%, and 4.5% of the collection, respectively. Overall, 527 (91%) isolates had an expanded-spectrum β-lactamase (ESBL) phenotype, with &lt;i>bla&lt;/i>&lt;s</pubmed_abstract><journal>mSphere</journal><pubmed_title>Genetic Predictive Factors for Nonsusceptible Phenotypes and Multidrug Resistance in Expanded-Spectrum Cephalosporin-Resistant Uropathogenic Escherichia coli from a Multicenter Cohort: Insights into the Phenotypic and Genetic Basis of Coresistance.</pubmed_title><pmcid>PMC9769571</pmcid><funding_grant_id>Gift fund</funding_grant_id><funding_grant_id>R01 AI117064</funding_grant_id><funding_grant_id>R01AI117064</funding_grant_id><pubmed_authors>Fee C</pubmed_authors><pubmed_authors>Huang YY</pubmed_authors><pubmed_authors>Riley LW</pubmed_authors><pubmed_authors>Crandall C</pubmed_authors><pubmed_authors>Miller S</pubmed_authors><pubmed_authors>Bittencourt CE</pubmed_authors><pubmed_authors>Kane I</pubmed_authors><pubmed_authors>Mastrangelo CF</pubmed_authors><pubmed_authors>Hufana C</pubmed_authors><pubmed_authors>Coralic Z</pubmed_authors><pubmed_authors>Tarlton NJ</pubmed_authors><pubmed_authors>Jackson N</pubmed_authors><pubmed_authors>Garner O</pubmed_authors><pubmed_authors>Allegretti YH</pubmed_authors><pubmed_authors>Chandrasekaran S</pubmed_authors><pubmed_authors>Noorbakhsh MH</pubmed_authors><pubmed_authors>Parker A</pubmed_authors><pubmed_authors>Frazee BW</pubmed_authors><pubmed_authors>Diaz J</pubmed_authors><pubmed_authors>Marcha JC</pubmed_authors><pubmed_authors>Awasthi S</pubmed_authors><pubmed_authors>Rodrigues-Wong P</pubmed_authors><pubmed_authors>deBoer TR</pubmed_authors><pubmed_authors>Borges CA</pubmed_authors><pubmed_authors>Belmont CR</pubmed_authors><pubmed_authors>Adams-Sapper S</pubmed_authors><pubmed_authors>Florence-Petrovic D</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genetic Predictive Factors for Nonsusceptible Phenotypes and Multidrug Resistance in Expanded-Spectrum Cephalosporin-Resistant Uropathogenic Escherichia coli from a Multicenter Cohort: Insights into the Phenotypic and Genetic Basis of Coresistance.</name><description>Antimicrobial resistance in urinary tract infections (UTIs) is a major public health concern. This study aims to characterize the phenotypic and genetic basis of multidrug resistance (MDR) among expanded-spectrum cephalosporin-resistant (ESCR) uropathogenic Escherichia coli (UPEC) causing UTIs in California patient populations. Between February and October 2019, 577 ESCR UPEC isolates were collected from patients at 6 clinical laboratory sites across California. Lineage and antibiotic resistance genes were determined by analysis of whole-genome sequence data. The lineages ST131, ST1193, ST648, and ST69 were predominant, representing 46%, 5.5%, 4.5%, and 4.5% of the collection, respectively. Overall, 527 (91%) isolates had an expanded-spectrum β-lactamase (ESBL) phenotype, with &lt;i>bla&lt;/i>&lt;s</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Dec</publication><modification>2026-06-12T09:58:01.073Z</modification><creation>2024-11-10T03:46:50.107Z</creation></dates><accession>S-EPMC9769571</accession><cross_references><pubmed>36377882</pubmed><doi>10.1128/msphere.00471-22</doi></cross_references></HashMap>